Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Roche image

Roche unveils plans for first Asian diagnostics plant

November 6, 2014
Medical Communications, Sales and Marketing Asia-Pacific, China, Roche, asia pacific, asian, manufacturing

Roche has said it will invest 450 million Swiss francs ($468m) in the construction of a diagnostics manufacturing facility in …

News
Roche image

Roche and Pharmacyclics agree leukaemia pact

October 17, 2014
Research and Development, Sales and Marketing BMS, CLL, Cancer, Gazyva, Pharmacyclics, Roche, imbruvica, leukaemia

Pharmacyclics’s cancer drug Imbruvica will be tested in combination with Roche’s Gazyva in a new partnership announced by the firms. …

News
Roche image

New cancer drugs escalate Roche earnings

October 16, 2014
Research and Development, Sales and Marketing Cancer, Herceptin (trastuzumab), Kadcyla, Perjeta, Q3, Roche, ado-trastuzumab emtansine, pertuzumab

Roche’s sales saw solid growth in the first nine months of the year, increased by the firm’s new cancer medicines. …

News
Boehringer image

Boehringer and Roche IPF drugs win FDA approval

October 16, 2014
Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, FDA, IPF, InterMune, Roche, US, lung scarring, lungs, ofev

The FDA has approved both Roche’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) for the treatment of the fatal lung …

News
Roche image

Roche falls foul of NICE rules, again

October 3, 2014
Medical Communications, Sales and Marketing CLL, Gazyvaro, NICE, Roche, blood cancer, oncology

Uncertainties in the data and high cost have seen NICE make an initial rejection of Roche’s new blood cancer drug …

News
Roche image

Roche’s Perjeta sees ‘impressive’ survival rates

September 29, 2014
Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid

Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …

News
Kadcyla image

Roche should be ‘shamed’ into lowering cancer drug price

September 16, 2014
Medical Communications, Sales and Marketing Kadcyla, Margaret Connolly, Roche, Swiss, breast cancer, trastuzumab emtansine

A public petition to force Roche to lower the cost of its costly new breast cancer drug Kadcyla has been …

News
nhs_parliament_2_8

UK pharma pays out £150m in drug rebates

September 12, 2014
Medical Communications, Sales and Marketing ABPI, PPRS, Roche, emms, rebate

The UK pharma industry has paid £150 million back to the government as part of its rebate to “underwrite the …

News
cancer_drip_2

Remembering the patient in the Cancer Drugs Fund debate

September 5, 2014
Medical Communications, Sales and Marketing Beating Bowel Cancer, Cancer Drugs Fund, Kadclya, Roche

Today Simon is a bowel cancer patient who is able to enjoy his weekly round of golf.After receiving the dreadful …

News
Google image

Google partners with AbbVie on ageing

September 4, 2014
Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google

Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …

News
Haslam image

NICE: Cancer Drugs Fund must use our processes

September 3, 2014
Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche

NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …

News
david_cameron

Government rips up blank cheque on cancer drugs

August 28, 2014
Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi

Pharma has priced itself out of the Cancer Drugs Fund as the rising costs of its new oncology treatments sees …

News
Pfizer Xalkori

US rivals Pfizer and Merck team up for lung cancer

August 27, 2014
Medical Communications, Research and Development, Sales and Marketing Merck, NSCLC, Roche, Xalkori, melanoma, pembrolizumab

The two biggest rival US pharma firms have joined forces to help develop a new combination treatment for certain non-small …

News
roche_glass_building

Roche pays $8.3bn for InterMune

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

News
Kadcyla packshot

Storm brewing over Roche cancer drug price

August 8, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Haslam, Kadcyla, NICE, Roche, Yervoy, rejection

The Breakthrough Breast Cancer charity and England’s drug pricing watchdog NICE have both attacked Roche for not lowering the price …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025